IQVIA Holdings Inc

NYSE:IQVUnited States

-- Overall spending in the U.S. market for medicines grew 2.5% in 2023, reaching $435Bn at net price level, reflecting a sharp decline in COVID-19 vaccines and therapeutics -- Spending growth was 9.9% when COVID-19 vaccines and therapeutics are excluded, driven by innovation in areas such as oncology, immunology, diabetes, and obesity -- Patient out-of-pocket costs increased due to the increasing use of GIP/GLP-1 agonists, which are approved and widely reimbursed for diabetes but are less commonly covered for obesity -- The number of patient visits, diagnostics and elective procedures fell 4-6% in 2023, while new prescriptions rose 4% RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--May 14, 2024--

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--May 09, 2024--
IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET (9:20 a.m. local PT).